NINDS HEAL Initiative plans RM1 grant for understanding mechanisms of therapeutic medical devices — neuromodulation mechanistic research funded
Summary
The NIH National Institute of Neurological Disorders and Stroke (NINDS) announced plans to release a HEAL Initiative Research Milestone (RM1) grant focused on understanding the mechanisms of therapeutic medical devices to improve patient outcomes, as noted in Neurotech Notables #51. The HEAL Initiative (Helping to End Addiction Long-term) has been one of the largest US federal research investments in pain and addiction neuroscience. Extending HEAL to mechanistic device research provides targeted NIH funding for the scientific questions that determine whether neuromodulation approaches for pain, addiction, and neurological disorders are optimally designed and targeted.
Why it matters
NINDS dedicating a HEAL Initiative RM1 specifically to understanding therapeutic device mechanisms addresses one of the biggest gaps in clinical neuromodulation: most approved devices were developed empirically without full mechanistic understanding. Funded mechanistic research determines optimal stimulation parameters, patient selection biomarkers, and indication expansion opportunities — exactly the knowledge that would allow DBS, SCS, VNS, and TMS to achieve their full therapeutic potential rather than the 3-9% patient penetration they currently achieve.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial